Plox helps over 100+ startups securely share their pitch deck
Investor Database / Section 32
Section 32
Fund Type
Venture Fund
Founding Year
2017
About
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Stages
Pre-Seed, Seed, Series A
Investments
91
Geography
San Diego, California
Exits
14
Sectors
Big Data & AnalyticsArtificial Intelligence & Machine Learning (AI/ML)Entertainment & MediaDeveloper ToolsBioTechMedical DevicePharmaceuticalsHealthcarePetTechInformation TechnologyPrivacySoftwareLife ScienceRoboticsHR TechInsurTechNanotechnologyAdvanced MaterialsEdTechCloudTechEnterpriseLogistics
Portfolio Companies
PrimerAspen NeuroscienceEmbarkMOMA TherapeuticsGretelC2i GenomicsCelsius TherapeuticsArbor BiotechnologiesNeocisWithMe HealthMekonosSyllableCharacter BiosciencesCulture BiosciencesSatellite BioCurrent HealthWise SystemsVerge GenomicsVinetiMiroculusROME TherapeuticsTwinStrand BiosciencesExai BioMedArrive